Sunitinib Efficacy Against Advanced Renal Cell Carcinoma
To access this article, please choose from the options below
Study received approval from the institution review board at each participating center.
Supported by Pfizer, Inc.
PII: S0022-5347(07)01766-1
doi:10.1016/j.juro.2007.07.030
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.

